崔俊明贊成政府引入雙價疫苗 倡為長者及免疫力低人士優先接種
香港醫院藥劑師學會會長崔俊明在電台節目表示,贊成政府引入復必泰BA.4或5雙價疫苗,相關疫苗的安全性無問題,認為疫苗有助針對新冠病毒產生更高的中和抗體。他又指,由於出現新變異病毒株,即使雙價疫苗的有效性僅較目前的疫苗多一點也是好,可以做到最好保護。
他表示,如果政府引入雙價疫苗,可優先接種的人士應是60歲或以上長者,以及免疫力低的人士。至於非高危人士或曾感染BA.4或BA.5病毒的人,可稍後才接種。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.